Contract with companies
Pfizer (PFZ) and BioNTech (BNT) have recently entered into an agreement with the European Commission to supply the official vaccine. Moreover, the agreement gives the opportunity to purchase 200 million doses and then another 100 million doses.
President of the European Union Commission V.D. Ursula said: "I am very pleased to announce today's agreement with BNT and Pfizer to purchase doses of coronavirus vaccine".
The purchase will only take place once the vaccine has been found to be an effective and safe EU medicines regulator.
Earlier, German Health minister announced that he expects the vaccine to appear in Europe in the first three months of 2021. But according to him, the vaccine could also appear on the European market by the end of 2020.
The EU has already signed agreements for the supply of COVID-19 vaccines with AstraZeneca, Sanofi and Johnson & Johnson. Negotiations on the supply of vaccines are also underway with Moderna, CureVac, and Novavax.
On Tuesday 10 November, Pfizer and BioNTech have announced that covid vaccine delivers 90 percent of the result. The companies also said that 94 out of 43,000 people were found to have infection during the trials. However, according to a number of experts, the vaccine's storage temperature of -70 degrees Celsius could prevent it from being delivered quickly around the world.